A Look At Acquisition Trends For Radiopharmaceuticals
By Adrian Toutoungi · July 11, 2024, 5:49 PM EDT
Therapeutic radiopharmaceuticals for oncology indications is one of the hot areas for investors and acquirers in 2024. This modality has built up real traction in the market, as evidenced by AstraZeneca...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login